TNF and inflammatory bowel disease: In contrast, a significant reduction in RBD-specific B cells was observed in patients with IBD treated with anti-TNFα (p = 0.0156 compared to visit three), to the point that the RBD-specific B cell populations were barely detectable in the three subjects analyzed (Figure 5B).